The Valley Desk

NCT02477696 · Interventional trial

Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)

Overall registry status Active not recruiting

Phase 3

Conditions Chronic Lymphocytic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov